A comparative study on sublingual versus oral and vaginal administration of misoprostol for late first and early second trimester abortion
- PMID: 21121402
A comparative study on sublingual versus oral and vaginal administration of misoprostol for late first and early second trimester abortion
Abstract
To compare the effectiveness, side-effects and outcome of sublingual with oral and vaginal administrations of misoprostol for induction of abortion in late first and early second trimester of gestation (9 to 16 weeks), a comparative observational study was carried out among 258 women with a period of gestation between 9 and 16 weeks, scheduled to have medical abortion, and randomly allocated into three groups and offered sublingual, oral and vaginal routes of misoprostol administration (400 mcg of misoprostol 6 hourly, maximum up to four dosages) respectively. Primary outcome measure was complete abortion rate and the secondary outcome measures were incidence of cases where surgical evacuation required, failure rate and induction-abortion interval. Development of side-effects and subjective assessment of patient's comfort with the different routes of administration were also recorded. Rate of complete abortion was higher in sublingual group in comparison to oral (p = 0.0338) and vaginal route (p = 0.5627). Surgical evacuation was required in less number of cases in sublingual group. Induction-abortion interval was also least with the sublingual route le, p < or = 0.0001 (versus oral) and 0.0011 (versus vaginal). Failure rate was highest with the oral route and least with the sublingual route. The patients were least comfortable with the vaginal route. Gastro-intestinal side-effects were least with the vaginal route, but significant vaginal bleeding (> 250 ml) was little bit higher with this route. Though misoprostol is effective in inducing medical abortion irrespective of the route of administration, sublingual route gives better results as compared to oral (statistically significant) and vaginal routes (in some respects, not of much statistical significance).
Similar articles
-
A randomised comparative study on sublingual versus vaginal administration of misoprostol for termination of pregnancy between 13 to 20 weeks.Aust N Z J Obstet Gynaecol. 2008 Apr;48(2):165-71. doi: 10.1111/j.1479-828X.2008.00831.x. Aust N Z J Obstet Gynaecol. 2008. PMID: 18366490 Clinical Trial.
-
A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.BJOG. 2005 Aug;112(8):1102-8. doi: 10.1111/j.1471-0528.2005.00638.x. BJOG. 2005. PMID: 16045525 Clinical Trial.
-
A prospective randomised comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy.BJOG. 2004 Sep;111(9):1001-5. doi: 10.1111/j.1471-0528.2004.00222.x. BJOG. 2004. PMID: 15327617 Clinical Trial.
-
The pharmacokinetics and different regimens of misoprostol in early first-trimester medical abortion.Contraception. 2006 Jul;74(1):26-30. doi: 10.1016/j.contraception.2006.03.005. Epub 2006 Apr 27. Contraception. 2006. PMID: 16781256 Review.
-
[Misoprostol: off-label use in the first trimester of pregnancy (spontaneous abortion, and voluntary medical termination of pregnancy)].J Gynecol Obstet Biol Reprod (Paris). 2014 Feb;43(2):123-45. doi: 10.1016/j.jgyn.2013.11.007. Epub 2014 Jan 13. J Gynecol Obstet Biol Reprod (Paris). 2014. PMID: 24433988 Review. French.
Cited by
-
Misoprostol Abortion: Ultrasonography versus Beta-hCG Testing for Verification of Effectiveness.Pak J Med Sci. 2013 Nov;29(6):1367-70. doi: 10.12669/pjms.296.3361. Pak J Med Sci. 2013. PMID: 24550955 Free PMC article.
-
COMPARISON BETWEEN SUBLINGUAL AND VAGINAL ROUTE OF MISOPROSTOL IN MANAGEMENT OF FIRST TRIMESTER MISCARRIAGE MISSING.Mater Sociomed. 2016 Jul 24;28(4):271-273. doi: 10.5455/msm.2016.28.271-273. Mater Sociomed. 2016. PMID: 27698600 Free PMC article.
-
Medical abortion through telehealth in India: a critical perspective.Sex Reprod Health Matters. 2021;29(2):2107090. doi: 10.1080/26410397.2022.2107090. Sex Reprod Health Matters. 2021. PMID: 36017949 Free PMC article. Review.